Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Private Advisor Group LLC

Private Advisor Group LLC cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.3% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 14,267 shares of the medical equipment provider’s stock after selling 643 shares during the period. Private Advisor Group LLC’s holdings in Intuitive Surgical were worth $7,447,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical during the 4th quarter worth approximately $26,000. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical during the third quarter worth approximately $33,000. Decker Retirement Planning Inc. acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth approximately $36,000. Sierra Ocean LLC acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth approximately $40,000. Finally, Capital Performance Advisors LLP acquired a new stake in shares of Intuitive Surgical during the third quarter worth approximately $38,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 408 shares of the business’s stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total transaction of $240,618.00. Following the sale, the executive vice president now directly owns 353 shares in the company, valued at approximately $208,181.75. The trade was a 53.61 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Jamie Samath sold 269 shares of the business’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the sale, the chief financial officer now owns 3,282 shares in the company, valued at $1,936,380. This trade represents a 7.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 6,348 shares of company stock valued at $3,587,582 in the last ninety days. Company insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the subject of several research analyst reports. BTIG Research boosted their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Barclays boosted their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Leerink Partners boosted their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. Finally, Wells Fargo & Company boosted their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Stock Down 2.4 %

Intuitive Surgical stock opened at $591.79 on Friday. The firm has a 50-day moving average price of $565.45 and a two-hundred day moving average price of $524.52. The firm has a market capitalization of $210.78 billion, a price-to-earnings ratio of 92.32, a PEG ratio of 5.87 and a beta of 1.39. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.